These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 498534)

  • 1. Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: serum creatine phosphokinase values in premenarchal, menstruating, postmenopausal and pregnant normal women.
    Smith I; Elton RA; Thomson WH
    Clin Chim Acta; 1979 Nov; 98(3):207-16. PubMed ID: 498534
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women.
    Bundey S; Crawley JM; Edwards JH; Westhead RA
    J Med Genet; 1979 Apr; 16(2):117-21. PubMed ID: 379337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.
    Perry TB; Fraser FC
    Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611
    [No Abstract]   [Full Text] [Related]  

  • 4. Variation of serum myoglobin levels in normal individuals. With reference to the use of myoglobin measurements for the detection of women carrying genes for the X-linked muscular dystrophies.
    Nicholson LV; Walls TJ
    J Neurol Sci; 1983 Dec; 62(1-3):41-58. PubMed ID: 6686846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier detection in Duchenne muscular dystrophy.
    Carter CO
    Lancet; 1979 May; 1(8123):979. PubMed ID: 87648
    [No Abstract]   [Full Text] [Related]  

  • 8. Creatine kinase activity in the detection of carriers of Duchenne muscular dystrophy: comparison of two methods.
    Tippett PA; Dennis NR; Machin D; Price CP; Clayton BE
    Clin Chim Acta; 1982 Jun; 121(3):345-59. PubMed ID: 7105400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. II. Review of methods of assay and factors which may be relevant in the interpretation of serum creatine phosphokinase activity.
    Gale AN; Murphy EA
    J Chronic Dis; 1979; 32(9-10):639-51. PubMed ID: 489704
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatine kinase levels in normal females.
    Satapathy RK; Skinner R
    J Med Genet; 1979 Feb; 16(1):49-51. PubMed ID: 469886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum myoglobin in muscular dystrophy and carrier detection.
    Nicholson LV
    J Neurol Sci; 1981 Sep; 51(3):411-26. PubMed ID: 7276986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier detection in Duchenne muscular dystrophy.
    Nicholson GA; Gardner-Medwin D; Walton JN
    Lancet; 1979 Aug; 2(8138):367. PubMed ID: 89433
    [No Abstract]   [Full Text] [Related]  

  • 14. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.
    Thompson MW; Murphy EG; McAlpine PJ
    J Pediatr; 1967 Jul; 71(1):82-93. PubMed ID: 5293863
    [No Abstract]   [Full Text] [Related]  

  • 15. Myoglobinemia in Duchenne muscular dystrophy carriers.
    Ando T; Kato T; Ohsawa M; Fukuyama Y
    Brain Dev; 1980; 2(1):87-8. PubMed ID: 7416442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral contraceptive pills on the level of creatine phosphokinase with regard to carrier detection in Duchenne muscular dystrophy.
    Simpson J; Zellweger H; Burmeister LF; Christee R; Nielsen MK
    Clin Chim Acta; 1974 Apr; 52(2):219-23. PubMed ID: 4828231
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 20. Carrier testing in families of isolated cases of duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity.
    Nicholson GA; Lane RJ; Gardner-Medwin D; Walton JN
    J Neurol Sci; 1981 Jul; 51(1):29-42. PubMed ID: 7252519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.